Biohaven (BHVN) Share-based Compensation (2021 - 2026)

Biohaven (BHVN) has 6 years of Share-based Compensation data on file, last reported at $28.3 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 46.69% year-over-year to $28.3 million; the trailing twelve-month figure through Mar 2026 stood at $70.6 million (down 21.65% YoY), and the FY2024 full-year result was $72.0 million, changed N/A from the prior year.
• Share-based Compensation improved to $28.3 million in Q1 2026, from $21.5 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $101.4 million in Q4 2022 to a low of $1.8 million in Q1 2022.
• A 5-year average of $27.4 million and a median of $18.9 million in 2022 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation surged 682.23% in 2022 and sank 92.06% in 2023, its largest moves.
• Tracing BHVN's Share-based Compensation over 5 years: stood at $101.4 million in 2022, then plunged by 95.61% to $4.5 million in 2023, then soared by 184.87% to $12.7 million in 2024, then soared by 69.65% to $21.5 million in 2025, then jumped by 31.35% to $28.3 million in 2026.
• Business Quant data shows BHVN's Share-based Compensation at $28.3 million in Q1 2026, $21.5 million in Q3 2025, and $20.8 million in Q2 2025.